Kinematic Assessment In Multiple Sclerosis

  • STATUS
    Recruiting
  • participants needed
    40
  • sponsor
    The Leeds Teaching Hospitals NHS Trust
Updated on 19 February 2024
weakness
multiple sclerosis

Summary

Multiple sclerosis (MS) affects more than a 120,000 people in the United Kingdom and is the commonest neurological condition in young adults. MS causes a number of symptoms including weakness, altered sensation, pain and memory difficulties. There are different forms of MS, including relapsing-remitting MS (RRMS), primary progressive MS (PPMS) and secondary progressive MS (SPMS). Currently there are several effective treatments for RRMS, but no NICE approved treatment for SPMS. Patients with PPMS and SPMS experience a gradual progression in disability that affects individual patients differently. A number of clinical scores are used to quantify the disability in individual patients and some of these scores focus on the patients' lower limb function. In the progressive forms of MS, preservation of upper limb function becomes a more important concern for patients to maintain their quality of life.

With the advent of new treatment trials for PPMS and SPMS, it is important that clinicians and researchers are able to use accurate and quantifiable measures of upper limb function to evaluate any changes with time or response to treatment. The use of motion tracking software provides a unique opportunity to accurately track movements in real time and space and give a tailored assessment of an individual's function.

The overall aim of this study is to use established kinematic assessment tools to explore the extent and progression of upper limb dysfunction in patients with progressive MS. This aim will be achieved via the following objectives:

  • Recruit a sample of participants with PPMS and SPMS from the local MS population
  • Quantify the physical impairment in these participants using existing clinical scores as well the kinematic assessment tools that have been developed
  • Follow-up the participants for a period of 12 months to identify and quantify any progression in their upper limb dysfunction
  • Identify any factors that may influence upper limb dysfunction in this group
  • Develop and evaluate the role of further kinematic techniques in this group of participants

Details
Condition Multiple Sclerosis, Multiple Sclerosis
Age 18-100 years
Treatment Boxed infrared gross kinematic assessment tool
Clinical Study IdentifierNCT04283071
SponsorThe Leeds Teaching Hospitals NHS Trust
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Age above 18 years at the time of enrolment into the study
Participants with a confirmed diagnosis of MS that have entered the primary or secondary progressive stage for at least 12 months
Participants must be able to comply with the terms and methods of the protocol
Study specific written informed consent has been obtained

Exclusion Criteria

Age below 18 years at the time of enrolment into the study
Participants with a diagnosis of RRMS
Participants unable to comply with the terms or methods of the protocol
Participants who report any cognitive or memory impairment
Participants with significant co-morbidities that affect their upper limb function i.e. stroke etc
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.